API reference
Etoricoxib
- CAS number
- 202409-33-4
- Molecular formula
- C18H15ClN2O2S
- Molecular weight
- 358.8 g/mol
About this molecule
Etoricoxib is a new COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Like any other COX-2 selective inhibitor, Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2) to reduce the generation of prostaglandins (PGs) from arachidonic acid. It is approved in more than 60 countries worldwide but not in the US.
Source: DrugBank, via PubChem.
Identifiers
- IUPAC name
- 5-chloro-2-(6-methyl-3-pyridinyl)-3-(4-methylsulfonylphenyl)pyridine
- InChIKey
- MNJVRJDLRVPLFE-UHFFFAOYSA-N
- SMILES
- CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C
- PubChem CID
- 123619
Also known as
Etoricoxib · Arcoxia · etoricoxibum · M01AH05 · Nucoxia · Tauxib · Etoricoxibe · Kingcox
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.